Scan beyond Lam Research and see which other AI infrastructure suppliers are getting rewarded for heavy R&D and facility build outs using our hand picked 55 AI infrastructure stocks
To own Lam Research, you need to believe AI driven chip complexity will keep pulling more spend into etch and deposition tools while the firm holds its technology edge. The Oregon lab build, higher R&D and healthy profitability all line up with that thesis. The board retirements and smaller director group look operationally minor for now. The more immediate swing factor remains wafer fab equipment spending patterns at a handful of large customers, especially in memory, and how that interacts with a relatively rich P/E multiple and already strong share price gains.
The dividend increase to US$0.33 a quarter is the clearest signal in this news run. It indicates that Lam Research is willing to return more cash even while it commits more than US$3b to AI focused labs. That balance matters if you are watching execution on large capex plans but do not want shareholder returns to become an afterthought. A higher payout also raises the bar on future free cash flow, which directly affects how resilient earnings remain if wafer equipment demand turns choppy again.
Even so, there is a pressure point in the Lam Research story that only really shows up once you zoom in on...
Read the full Lam Research narrative to see the case behind these numbers.
Lam Research's current analyst narrative points to US$45.8b in revenue and US$17.3b in earnings by 2029. This outlook is built on 25.4% yearly revenue growth and an earnings increase of about US$10b from US$7.3b today.
Lam Research's forecasts put fair value at $370.87 versus the $307.65 share price, indicating a 21% upside to its current price that could narrow fast.
Another angle to watch is the bullish view that Lam Research could win more market share than consensus implies. The most optimistic analysts were already modeling about US$54.2b of revenue and US$19.6b in earnings by 2029 before this dividend hike and Oregon lab plan, so board changes and higher payouts may push those narratives in new directions.
If you want a quick reality check on where others think Lam Research should trade, scan the 6 other fair value estimates for Lam Research next.
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
Once you have a view on Lam Research, it helps to broaden the field and compare it with other opportunities that match different goals, whether you care more about value, stability, or income.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com